Бекарбон

Quick links to important sections

Бекарбон

Treatment option: Gastritis, Dyspepsia

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Бекарбон

Quick Facts

Property Description
Active Ingredients Belladonnae Folia Extract, Sodium Hydrocarbonate
Dosage Form Tablets
Pharmacological Class Gastrointestinal Agent, Antispasmodic/Antacid
Route of Administration Oral
Origin Type Combined (Herbal and Synthetic)

The Core Identity of Бекарбон: A Combined Gastrointestinal Agent

Бекарбон is classified as a combined drug and is administered orally in the established dosage form of tablets. This medication belongs to the specialized pharmacological classification of gastrointestinal agents, distinguishing itself by providing the integrated action of both an Antispasmodic and an Antacid. The Belladonna component contains naturally occurring alkaloids, primarily atropine and hyoscyamine, placing it within the class of Muscarinic Antagonists. This dual functional profile is specifically designed for the symptomatic management of digestive discomfort where both muscle cramping and acid-related irritation are contributing factors.

Dual Composition: Herbal Extract and Synthetic Antacid

The composition of Бекарбон relies on two distinct active ingredients: Belladonnae Folia Extract and Sodium Hydrocarbonate. The Belladonna extract provides the herbal component, contributing the anticholinergic properties that act on smooth muscle tone and secretions. Conversely, Sodium Hydrocarbonate is the synthetic component responsible for the immediate antacid effect, rapidly neutralizing stomach acid. This preparation is differentiated by this specific combination of a plant-derived alkaloid and a fast-acting inorganic salt, a formulation frequently utilized for non-specific functional dyspepsia. Preparations containing belladonna alkaloids act to reduce gastrointestinal motility.

General Role and Purpose

The primary general purpose of Бекарбон is to provide targeted, dual symptomatic relief. The antispasmodic action focuses on relaxing the involuntary, painful contraction of the smooth muscles within the digestive system. The concurrent antacid action of the Sodium Hydrocarbonate offers rapid counteraction to excessive hydrochloric acid. This integrated effect supports the general alleviation of acute discomfort caused by both muscular spasms and the accompanying feeling of hyperacidity.

What side effects are possible with Бекарбон?

Possible Side Effects and Safety Information

Official safety documents define the side effect profile of Бекарбон based on the combined action of its two active ingredients: Belladonnae Folia Extract (anticholinergic) and Sodium Hydrocarbonate (antacid/electrolyte-affecting).

The most common adverse effects associated with the Belladonna component stem from its anticholinergic properties and are classified in governmental health information as More Common. These typically involve the nervous, ocular, and gastrointestinal systems, including dry mouth, constipation, and blurred vision. Rare effects, such as eye pain, have also been documented.

Adverse reactions linked to the Sodium Hydrocarbonate component generally affect the metabolism, and are often listed with a Not Known frequency in regulatory documents. These include metabolic alkalosis, fluid retention, hypokalaemia, and gastrointestinal discomfort such as nausea and flatulence.

Serious Adverse Reactions and Safety Constraints

Official safety information highlights the risk of clinically significant events. The potential for metabolic alkalosis and sodium overloading is explicitly documented with prolonged use. The risk of serious adverse reactions, including seizures and fever, is noted to be increased in infants and children due to their sensitivity to Belladonna alkaloids. Caution is required in patients with renal impairment due to the heightened risk of metabolic alkalosis.

The regulatory profile emphasizes that Belladonna has a high potential for toxicity even at low doses, and that the antacid component may alter the effects of other medicines due to changes in urine and gastric pH.

Overdose and Emergency Response

Overdose of Бекарбон, a combination product containing Belladonna alkaloids and Sodium Bicarbonate, can result in the signs of severe anticholinergic toxicity and metabolic disturbance. The official regulatory profile details these specific documented presentations to guide emergency response.

Documented Overdose Manifestations

System Documented Signs/Symptoms
Anticholinergic Toxicity Hot, dry skin; greatly dilated pupils (mydriasis); blurred vision; severe dry mouth; pronounced tachycardia (rapid heart rate); and hyperpyrexia (high fever).
CNS Effects Restlessness, excitement, agitation, delirium, confusion, and progressing to stupor or coma.
Metabolic Effects Signs of metabolic alkalosis, hyperirritability, and muscle twitching or tetany.

Emergency Action and Urgent Medical Help

Regulatory documents explicitly state that immediate medical attention is required upon the development of any suspected signs of overdose. This is particularly urgent for severe symptoms such as loss of consciousness, convulsions, extreme heart rate changes, or difficulty breathing, which may signify life-threatening outcomes including respiratory failure or circulatory collapse.

Management procedures officially include discontinuing the drug, initiating supportive care, and may involve the use of activated charcoal or a specific antidote (e.g., physostigmine) for severe anticholinergic effects. Close monitoring of cardiac function and blood parameters in a clinical setting is required.

Therapeutic Uses of Бекарбон

What Бекарбон Treats: Main Uses and Benefits

Бекарбон (Bekarbon) is applied across therapeutic domains where supportive symptomatic assistance is needed for the digestive system, relevant in contexts involving heightened systemic burden. The medicine is commonly used to help with symptoms related to systemic imbalance and physical discomfort.

The primary uses focus on conditions presenting with systemic or localized discomfort, such as heartburn, acid indigestion, and upset stomach. Oral sodium bicarbonate is utilized within this context for such digestive concerns. The medicine is also applied in addressing symptoms of increased neurological or muscular activity, relevant for easing symptoms that create noticeable physiological strain, often during acute or episodic changes.

Overall, the product provides support that helps ease the overall symptom burden, particularly during phases when symptoms become more noticeable. This kind of supportive relief may help patients cope more steadily with symptom fluctuations.

Quick Fact: Supports in managing Heartburn

“The product contributes to improved comfort during periods of heightened symptoms.”

Regulatory References

  1. Sodium Bicarbonate - StatPearls - NCBI Bookshelf

Eligibility and Restrictions for Use

Бекарбон (Bekarbon), a combination product containing Belladonna extract, is subject to strict regulatory constraints based on its anticholinergic activity.

Contraindicated Populations (Must Not Use)

Use of Бекарбон is absolutely contraindicated for several groups, primarily due to the risks associated with the Belladonna component:

  • Children and Adolescents: Prohibited for anyone under 18 years of age.
  • Pregnancy and Lactation: Prohibited during pregnancy and breastfeeding.
  • Hypersensitivity: Individuals with known hypersensitivity to any component of the medicine.

Contraindicated Conditions

Official labeling prohibits use in patients with specific clinical conditions where anticholinergic effects are dangerous, including glaucoma, prostatic hypertrophy (enlargement), mechanical obstruction of the intestines, intestinal atony, and certain forms of ulcerative colitis.

Restricted Use and Special Caution

Use is restricted and requires special medical caution in eligible adults with certain pre-existing conditions:

  • Organ Impairment: Patients with impaired hepatic (liver) function or impaired renal (kidney) function.
  • Cardiac Conditions: Individuals with certain cardiovascular diseases, such as tachycardia or chronic heart failure.
  • Older Adults: While not prohibited, older adults may require special monitoring due to increased sensitivity to anticholinergic effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Бекарбон, derived from the regulatory profiles of its components: Belladonnae Folia Extract (anticholinergic) and Sodium Hydrocarbonate (antacid).

Formal Restrictions and Contraindications

Co-administration with Non-selective Monoamine Oxidase Inhibitors (MAOIs) is a contraindicated combination due to the risk of intensifying the Belladonna component's anticholinergic effects. A mandatory timing separation is also required for certain products: other antacids or anti-diarrhea medicines should not be taken within one hour of Бекарбон, as they may reduce the absorption and effectiveness of the Belladonna alkaloids.

Documented Interaction Categories

Interaction Type Interacting Substance/Class Regulatory Basis
Pharmacodynamic Overlap Alcohol (Ethanol); CNS Depressants (e.g., Sedatives); Solid Potassium Chloride Risk of additive side effects (CNS depression) or increased local GI injury.
Exposure Modification Amphetamine; Alendronic acid Reduced clearance (Amphetamine concentration increased) or reduced absorption (Alendronic acid concentration decreased) due to pH changes.

Population-Specific Notes

Regulatory cautions specify that the effects and potential severity of interactions may be increased in certain populations. Elderly patients have an officially noted higher sensitivity to anticholinergic effects. Similarly, caution is advised for patients with Kidney Disease or Liver Disease, as slower clearance may lead to increased drug exposure and interaction risk.

Mechanism of Action

Neutralizing Gastric Acid and Buffering Capacity

Бекарбон acts through two distinct mechanistic domains to modulate the gastrointestinal (GI) environment. The first domain involves the alkalizing compound (sodium bicarbonate), which functions as a chemical buffer. This substance rapidly consumes and neutralizes excess hydrogen ions (mathrmH^+) present in the stomach's lumen via an acid-base reaction. This chemical neutralization increases the gastric mathrmpH, thereby affecting the mathrmpH-sensitive enzymatic activity and protein integrity within the proximal GI tract. The interaction is immediate and purely chemical, modifying the physiochemical environment directly.


Physical Adsorption and Modulation of Cholinergic Signaling

The second domain is mediated by a compound with adsorbent properties. This substance facilitates physical adsorption by binding non-covalently to various molecular species, including gases and small molecules, within the GI lumen. Additionally, this compound exerts an anticholinergic effect through the modulation of key pathways involving peripheral acetylcholine receptors. This interaction influences the signaling cascades regulated by the parasympathetic autonomic nervous system, leading to altered smooth muscle activity within the GI system.

Dosage and Administration Information

How to Use Becarbon (Бекарбон): Administration Guidelines

Becarbon is an oral medication administered following specific guidelines. Adherence to the prescribed dose, frequency, and timing relative to meals is essential for proper use.

Administration and Dosing

Administration Scope Standard Instruction
Route of Administration Oral (swallowed)
Dosage Form Tablet
Standard Single Dose (Adult) 1 tablet
Frequency 2 to 3 times per day
Maximum Daily Dose 15 tablets

Administration Requirements

Timing and Preparation:

Becarbon tablets must be taken 30–40 minutes before meals. The tablet should be swallowed whole (not chewed or crushed) and washed down with a sufficient amount of water to facilitate ingestion. Use of the lowest effective dose possible is required.

Duration of Use:

Treatment with Becarbon is intended to be short-term and symptomatic. If symptoms persist or fail to improve within 3 to 5 days of initiation, treatment must be reviewed, and a physician should be consulted regarding further use.

Population-Specific Rules

Becarbon is not recommended for use in children and adolescents under the age of 18, as safety and efficacy data for this age group are generally absent. No specific dose adjustments are typically detailed for geriatric patients or those with mild renal or hepatic impairment, implying the standard adult dose is used unless contraindicated.

Recent Clinical Evidence

1. Research Evidence for Managing Gastrointestinal Spasms

The research base for the antispasmodic component (belladonna alkaloids) includes systematic reviews and historical controlled trials. These studies evaluated the outcomes related to anticholinergic compounds in adults with conditions characterized by fluctuating manifestations, such as functional gastrointestinal disorders. Findings reflect formulations where belladonna was often studied in combination with other agents, and research examined measures like spasm frequency and symptom scores over short-to-intermediate timeframes.

2. Evidence Supporting Acute Acid Neutralization and Heartburn Relief

The research base for the antacid component (Sodium Hydrocarbonate) relies on pharmacological documentation. Research examined how this compound possesses a capacity for rapid acid neutralization. Studies monitored this temporary physiological imbalance, evaluating patient-reported outcomes describing perceived discomfort and speed of acid reduction in acute settings.


3. Study Design and Comparison with Other Treatments

The overall evidence landscape is a mix of historical clinical trials and regulatory data. Components was studied for their properties compared to both placebo and other agents. The evidence quality varies across studies, and the specific combination may not have been the subject of recent, large-scale comparative research.


4. Long-Term Data, Durability, and Follow-up Periods

The research available generally focuses on short-term symptom changes and immediate effects. Consequently, the follow-up durations were limited. Long-term effects are not fully established, meaning there is limited information for long-term outcomes or the durability of the described patterns of relief.


5. Evidence in Specific Patient Groups

The existing evidence base primarily describes patterns related to the general adult population. Data for certain groups remain insufficient, including children or very elderly individuals. Dedicated clinical research programs focusing on these precise demographic groups was not observed in primary research summaries.


6. Research Gaps and Unanswered Questions

Sample sizes were modest in some older trials, and the findings were mixed, suggesting that certainty remains low. The research gap concerns the availability of recent, large-scale randomized controlled trials dedicated to studying this specific two-component formulation. Evidence highlights what is known — and what is still uncertain.

Key Studies & References Sodium Bicarbonate (StatPearls)

Frequently Asked Questions (FAQ)

Common questions about Бекарбон (FAQ)

Q: How quickly can I expect to notice the effect of Бекарбон?

A: Official regulatory documents describe the antacid component of Бекарбон as having a rapid acid neutralization capacity. This chemical reaction, which helps reduce stomach acidity, is characterized as immediate upon contact. The antacid function is described as providing rapid acid neutralization.

Q: Is Бекарбон a type of antacid?

A: Yes, the medicine is officially classified as a combined drug because it contains both an Antispasmodic component and an Antacid component (Sodium Hydrocarbonate). This dual classification means it is intended to address both muscle spasms and acid-related irritation.

Q: Can I take Бекарбон if I am already taking supplements or vitamins?

A: The antacid ingredient in Бекарбон can alter the pH balance in the stomach, which in turn may affect how the body absorbs certain substances. Regulatory caution emphasizes that the potential for interactions with other substances, including supplements, necessitates consultation with a healthcare provider prior to use.

Q: What is the difference in action between Бекарбон and a simple digestive enzyme?

A: Бекарбон's functional role is two-fold: it neutralizes excess stomach acid and contains a component that modulates the smooth muscle activity of the digestive system. This mechanism is different from that of a simple digestive enzyme, whose primary function is to help the body break down food.

Q: What is the main difference between Бекарбон and regular stomach remedies?

A: The primary difference described in official documents is that Бекарбон is a combined drug providing a dual approach. It delivers both an antispasmodic action to relax painful muscle contractions (spasms) and an antacid action to rapidly neutralize excessive stomach acid. This distinguishes it from monotherapy remedies that address only one of these factors.

Q: Is Бекарбон used for heartburn or just for spasms?

A: According to official product information, the primary purpose is the symptomatic management of digestive discomfort where both muscle spasms (cramping) and acid-related irritation are contributing factors. The medicine is therefore designed to help alleviate both acid-related discomfort and muscle-related pain in the digestive system.

Q: Does Бекарбон make you drowsy or affect driving?

A: The Belladonna component can cause effects that may interfere with alertness and coordination. The most common adverse effects listed in official documents include dizziness, blurred vision, and dry mouth. The presence of these effects necessitates awareness of potential impact on tasks requiring concentration, such as driving.

Q: Are there any common foods or drinks that interact with Бекарбон?

A: Official interaction warnings primarily relate to other medicines and the risk associated with combining the product with Alcohol (Ethanol). Co-administration with alcohol is specified as posing a risk of additive side effects, which may include central nervous system (CNS) depression.

Q: Do studies suggest Бекарбон helps with long-term stomach issues?

A: Official regulatory guidelines intend for the treatment to be short-term and symptomatic. Research summaries note that the available evidence primarily focuses on short-term symptom changes, and long-term effects are not fully established due to limited follow-up durations in the studies examined.

Q: Can I use Бекарбон if I have high blood pressure?

A: Official safety information notes that caution is advised for patients with certain cardiovascular diseases. Additionally, the antacid component (Sodium Hydrocarbonate) carries a documented risk of sodium overloading with prolonged use, a factor often monitored in individuals with high blood pressure.

Q: What should I do if I accidentally take two tablets instead of one Бекарбон?

A: Official safety information notes that the Belladonna component in the product has a high potential for toxicity even at low doses. Official documentation notes that the administration requires the use of the lowest effective dose possible. The regulatory profile emphasizes adherence to official administration procedures due to the Belladonna component.

Q: How does Бекарбон relate to treatments for stomach ulcers?

A: The primary role of Бекарбон is to provide symptomatic relief for the muscle spasms and hyperacidity associated with digestive discomfort. It is not intended as a curative treatment for ulcers, and official labeling explicitly contraindicates its use in patients with certain specific forms of ulcerative colitis.

Q: Is Бекарбон known to cause stomach upset or diarrhea?

A: Regulatory documents list several gastrointestinal adverse effects associated with the product, including nausea and flatulence. The Belladonna component's anticholinergic effects also lead to constipation as a more common side effect, while diarrhea is not listed.

Q: Are there different forms of Бекарбон available, like liquid or capsules?

A: According to the established regulatory profile and official product information, the medicine is available and administered orally only in the dosage form of tablets.

Q: Why do people sometimes say Бекарбон helps with 'stomach anxiety'?

A: The Belladonna component in the medicine has an anticholinergic effect, meaning it influences the signaling of the parasympathetic autonomic nervous system in the gut. This modulation affects smooth muscle activity in the digestive tract, which may be perceived as a calming effect on gastrointestinal discomfort.

Q: Are there any warnings about using Бекарбон with alcohol?

A: Yes, the official interaction section lists Alcohol (Ethanol) as a substance that should be used with caution. Combining the product with alcohol is associated with a risk of additive side effects, which primarily manifest as central nervous system (CNS) depression.

Q: Does Бекарбон affect the way other medicines are absorbed?

A: Yes, official documents state that the antacid component, Sodium Hydrocarbonate, works by changing the gastric pH (acidity level) of the stomach. This chemical change can, in turn, affect the way other medicines taken at the same time are absorbed into the body.

Q: How does Бекарбон help with stomach spasms?

A: The product contains an antispasmodic component (Belladonna extract) designed to target and relax the involuntary, painful contractions of the smooth muscles that line the digestive system. This action helps to alleviate the cramping and discomfort associated with spasms.

Q: Is it necessary to drink a full glass of water when taking Бекарбон?

A: Official instructions require the tablet to be swallowed whole and washed down with a sufficient amount of water to ensure proper ingestion and passage. While the instructions do not specify a 'full glass,' they emphasize that the amount must be adequate to facilitate swallowing.

Q: Does long-term use of Бекарбон have any specific known risks?

A: Official safety information explicitly documents potential risks associated with prolonged use, including the possibility of metabolic alkalosis and sodium overloading. The treatment is intended for short-term, symptomatic relief.

Q: What if Бекарбон doesn't seem to be working for my discomfort?

A: According to the official duration of use guidelines, if symptoms persist or fail to improve within 3 to 5 days of starting treatment, the use of the medicine must be reviewed. If symptoms persist or fail to improve, official guidelines recommend that the treatment be reviewed and a physician consulted.

Q: Is Бекарбон a natural remedy or a synthesized medicine?

A: Regulatory documents classify the product as a combined drug because it contains two different active ingredients. One is the herbal component (Belladonna extract), and the other is a synthetic component (Sodium Hydrocarbonate), which is a fast-acting inorganic salt.

Q: Does Бекарбон have any effects on stool color or consistency?

A: Official safety information reports that one of the more common adverse effects associated with the Belladonna component is constipation, which represents a change in stool consistency. Effects on stool color are not addressed in the regulatory summaries.

Q: What kind of evidence is available about Бекарбон's effectiveness?

A: The research base for the product is described as a mixture of historical controlled trials and pharmacological documentation supporting the actions of its individual components. Official research summaries indicate that the overall evidence quality varies across studies, and some evidence relies on older data.

How should Бекарбон be stored and disposed of?

Official Storage and Disposal Instructions

Regulatory documents define specific conditions required to maintain the stability and quality of Бекарбон tablets, particularly due to the presence of both Belladonna alkaloids and Sodium Hydrocarbonate.

Storage Requirement Official Instruction
Temperature Limit Do not store above 25 C
Environmental Protection Store in a dry place and protect from moisture and light.
Packaging Rule Must be kept in the original, tightly closed package.
Product Longevity Unopened product stability is confirmed for 36 months under required conditions.
Child Safety Keep out of the sight and reach of children.

Any unused or expired Бекарбон must be disposed of according to local regulations. This medication is not classified as a hazardous waste and should not be discarded into household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Бекарбон found in:

A-Z Index: